Studies confirmed that patients with increased ZEB1-AS1 possessed worse overall survival and disease-free survival in esophageal cancer [11]; and upregulated ZEB1-AS1 was an independent poor prognostic factor of patients with hepatocellular carcinoma [9]. Here, ZEB1 is linked to hepatocellular carcinoma.